Pages that link to "Q37971612"

The following pages link to Peripheral cholesterol, metabolic disorders and Alzheimer's disease (Q37971612):

Displaying 13 items.

• Cholesterol homeostasis: a key to prevent or slow down neurodegeneration (Q21129248) (← links)
• Cholesterol in brain disease: sometimes determinant and frequently implicated (Q34621446) (← links)
• Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). (Q36103515) (← links)
• Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease (Q36771721) (← links)
• LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals (Q36781712) (← links)
• Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis (Q37148306) (← links)
• Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease (Q38034089) (← links)
• Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro (Q38861519) (← links)
• Sodium thiosulphate attenuates brain inflammation induced by systemic lipopolysaccharide administration in C57BL/6J mice. (Q40205263) (← links)
• Membrane properties that shape the evolution of membrane enzymes. (Q52337817) (← links)
• Neuroprotective effects of statins against amyloid β-induced neurotoxicity. (Q52689881) (← links)
• Identification of Differentially Expressed Profiles of Alzheimer's Disease Associated Circular RNAs in a Panax Notoginseng Saponins-Treated Alzheimer's Disease Mouse Model (Q59806518) (← links)
• Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease (Q91762131) (← links)